A Roadmap for the Implementation of Continued Process Verification

References

1. 1.↵
   BioPhorum Operations Group. Continued Process Verification: An Industry Position Paper with Example Plan, 2014).
2. 2.↵
   U.S. Food and Drug Administration. Guidance for Industry, Process Validation: General Principles and Practices, 2011. From http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.
3. 3.↵
   CASSS CMC Biotech Working Group. A-MAB: a Case Study in Bioprocess Development, 2009. From http://www.casss.org/?page=286.
4. 4.↵
   European Medicines Agency. (2014). DRAFT: Guideline on Process Validation for the Manufacture of Biotechnology-Derived Active Substances and Data To Be Provided in the Regulatory Submission. From http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500165805&murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc.
5. 5.↵
   International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Pharmaceutical Quality System Q10, 2008. From http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html.
6. 6.↵
   1. Bissell A.F.

   “How Reliable is Your Capability Index?” Journal of the Royal Statistical Society. Series C (Applied Statistics), Vol. 39, No. 3 (1990) pp. 331–340.

   OpenUrl
7. 7.↵
   1. Shewhart W. A.

   Economic Control of Quality of Manufactured Product; D. Van Nostrand Company, Inc.: New York, 1931.